How is Physical Activity Measured in Spinal Muscular Atrophy and Duchenne Muscular Dystrophy?
Journal of Neuromuscular Diseases · 08.09.2023 · 10 (5) · 897-914
DOI: 10.3233/jnd-230033 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neuromuscular Diseases, online erschienen am 03.07.2023. Verfasst von David Uher und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation and Regenerative Medicine, Columbia University Irving Medical Center, New York, NY, USA. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Muscular Atrophy, Spinal, Neuromuscular Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Physical activity (PA) provides many substantial benefits to help reduce risk for cardiometabolic disease, improve cognitive function, and improve quality of life. Individuals with neuromuscular disorders (NMDs), such as spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD) are characterized by muscular weakness and fatigue, which limits the capacity to reach the recommended guidelines of PA. Measuring PA in these populations can provide insight to participation in daily activities, track disease progression, and monitor efficacy of drug treatments.
Objective
The objective of this study was to identify how PA is measured in SMA and DMD using instrumented and self-report methods, and how these methods are employed in ambulatory and non-ambulatory groups.
Methods
A scoping review was performed to identify studies that reported PA in these neuromuscular disorders. Inclusion was determined after a multi-stage review process by several reviewers, followed by an in-depth analysis of metrics reported by each tool that was used.
Results
A total of nineteen studies were identified and included in this review. Sixteen studies included instrumented measures and four studies utilized self-reported measures, with eleven studies also reporting PA information from a non-ambulatory group. A variety of metrics have been reported using both classes of measurement tools.
Conclusion
Although a wide variety of research exists that details both instrumented and self-reported measurement tools, feasibility, cost, and study aims are important factors to consider in addition to testing methodology when selecting which type of tool to use. We recommend using a combination of instrumented and self-report measures to provide context to the PA measured in these populations. Improvements in both instrumented and self-report methodologies will add valuable knowledge about the disease burden and efficacy of treatment and disease management methods in SMA and DMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rehabilitation and Regenerative Medicine, Columbia University Irving Medical Center, New York, NY, USA.
- Department of Biobehavioral Sciences, Teachers College, Columbia University, New York, NY, USA.
Zitieren
APA
Uher, D., Yoon, L., Garber, C. E., & Montes, J. (2023). How is Physical Activity Measured in Spinal Muscular Atrophy and Duchenne Muscular Dystrophy?. Journal of Neuromuscular Diseases, 10(5), 897-914. https://doi.org/10.3233/jnd-230033
Vancouver
Uher D, Yoon L, Garber CE, Montes J. How is Physical Activity Measured in Spinal Muscular Atrophy and Duchenne Muscular Dystrophy?. Journal of Neuromuscular Diseases. 2023;10(5):897-914. doi:10.3233/jnd-230033
BibTeX
@article{Uher2023,
author = {Uher, David and Yoon, Lisa and Garber, Carol Ewing and Montes, Jacqueline},
title = {How is Physical Activity Measured in Spinal Muscular Atrophy and Duchenne Muscular Dystrophy?},
journal = {Journal of Neuromuscular Diseases},
year = {2023},
volume = {10},
number = {5},
pages = {897--914},
doi = {10.3233/jnd-230033}
}
EUVIMED